Results 181 to 190 of about 150,574 (342)

Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT In human medicine, the choice of medical terminology influences patients' choice of management options and associated anxiety levels in relation to their diagnoses. The objective of this study was to determine the association between canine caregiver's treatment choices and anxiety levels when papillary thyroid cancer is described with or ...
Bryanna M. Glasspool, Laura Blackwood, Kelly L. Bowlt Blacklock   +2 more
wiley   +1 more source

Current trends in the management of well differentiated papillary thyroid carcinoma. [PDF]

, 1996
Barbara Solomon, Leonard Wartofsky, Kenneth D. Burman   +2 more
openalex   +1 more source

Improvement in short‐term outcome over time, in a single center embarking on a canine mitral valve repair program using a structured multidisciplinary approach

Veterinary Surgery, EarlyView.
Abstract Objective To describe a structured approach to the development of a mitral valve repair (MVR) program for dogs with myxomatous mitral valve disease (MMVD) and to document the change in short term outcome over time. Study design Clinical prospective study. Animals Dogs (n = 132) with MMVD undergoing MVR at a single hospital.
Daniel J. Brockman, Thomas D. Greensmith, Matteo Rossanese, Alison Young, Sarah L. Carey, Adrian Boswood, Thaleia‐Rengina Stathopoulou, Carolina Palacios Jimenez, Nigel Cross   +8 more
wiley   +1 more source

Cytofluorometric DNA analysis in different histological patterns of thyroid papillary carcinoma.

, 1994
Tetsuro Saka, Yuzo Yamamoto, Takashi Itoh, Isao Inoue, Masashi Imanaka, HUMIYUKI OKATO, Hiroaki Takahashi   +6 more
openalex   +2 more sources

Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas [PDF]

, 1996
Sissy Jhiang
openalex   +1 more source

AXL and SRC in clear cell renal cell carcinoma: absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosis

The Journal of Pathology: Clinical Research, Volume 11, Issue 3, May 2025.
Abstract Novel treatment options for metastatic renal cell carcinomas (RCC) include specific MET inhibitors, GAS6/AXL inhibitors, and SRC inhibitors. The interplay between c‐MET, SRC, AXL expression, and their gene mutation patterns in different renal carcinoma subtypes is unclear. To improve the understanding of these signaling pathways, we analyzed c‐
Muriel D Brada, Tülay Karakulak, Peter Schraml, Martina Haberecker, Dorothea Rutishauser, Jeffrey S Ross, Daniel Eberli, Holger Moch   +7 more
wiley   +1 more source

Papillary thyroid microcarcinoma with large and cystic neck metastasis: report of a case and review of articles

Journal of Research in Medical Sciences, 2006
Papillary microcarcinoma of thyroid (PMC) as a variant of papillary carcinoma less than 1 cm in size is a new clinicopathological entity, with high incidence and good prognosis.
Mehrdad Katebi, Ghodratollah Maddah, Mahdi Tarhini, Ali Fawzi   +3 more
doaj  

Prognostic impact of EGF-receptor in papillary thyroid carcinoma

, 1993
LA Akslen, AO Myking, Helga B. Salvesen, JE Varhaug   +3 more
openalex   +1 more source

Thyroid papillary carcinoma of columnar cell type [PDF]

, 1998
Bruce M. Wenig, Lester D.�R. Thompson, Carol F. Adair, Barry M. Shmookler, Clara S. Heffess   +4 more
openalex   +1 more source

Cytopathology of follicular and oncocytic follicular thyroid neoplasms: A Bethesda System perspective

Cancer Cytopathology, Volume 133, Issue 5, May 2025.
Abstract The third edition of The Bethesda System for Reporting Thyroid Cytopathology includes category IV, follicular neoplasm (FN), which is used to classify fine‐needle aspirates of thyroid nodules that may correspond to invasive follicular‐derived neoplasia other than papillary thyroid carcinoma.
André Lametti, Fadi Brimo, Yonca Kanber, Derin Caglar, Manon Auger   +4 more
wiley   +1 more source